深度表型样本中物质使用障碍的全表型关联分析
研究利用 Yale-Penn 深度表型样本(n=10,610,含遗传数据;46.3% 非洲裔,53.7% 欧洲裔),分析酒精使用障碍、阿片使用障碍、吸烟起始和终生大麻使用 4 种物质相关特征的多效性。结果显示,在非洲裔个体中酒精使用障碍的多基因风险评分(PRS)与其各自的主要 DSM 诊断相关,在欧洲个体中酒精使用障碍、阿片使用障碍和吸烟起始的 PRS 与相应主要 DSM 诊断相关;这些 PRS 还涉及同一物质的其他表型。欧洲个体的 PRS 全表型关联分析在多个表型域中发现关联,包括家庭环境和早期童年经历等不常评估的表型。
要点
- 深度表型样本可补充大型生物库遗传研究,提供更细的表型粒度。
- 酒精使用障碍、阿片使用障碍和吸烟起始的 PRS 与各自主要 DSM 诊断相关。
- PRS 还关联同一物质的其他表型及家庭环境、早期童年经历等域。
核心结论
- 较小但深度表型的样本能补充大型生物库遗传研究,提供更细的表型粒度,有助于识别障碍具体特征与物质使用障碍遗传易感性之间的关联。
研究设计与样本
- 研究使用 Yale-Penn 深度表型样本,n=10,610 有遗传数据;46.3% 非洲裔,53.7% 欧洲裔。
- 样本包括受影响者和对照,使用半结构化药物依赖和酒精滥用评估访谈进行综合精神科评估。
- 分析 4 种物质相关特征:酒精使用障碍、阿片使用障碍、吸烟起始和终生大麻使用。
主要发现
- 在非洲裔个体中,酒精使用障碍的 PRS 与其主要 DSM 诊断相关。
- 在欧洲个体中,酒精使用障碍、阿片使用障碍和吸烟起始的 PRS 与各自主要 DSM 诊断相关。
- 这些 PRS 还与涉及同一物质的其他表型相关。
- 欧洲个体的 PRS 全表型关联分析在多个表型域中发现关联,包括家庭环境和早期童年经历等不常评估的表型。
临床怎么用
- 在精神心理科评估中,可关注物质使用障碍患者同一物质的其他表型及家庭环境、早期童年经历等特征。
- 深度表型信息有助于理解物质使用障碍的遗传多效性通路,为个体化评估提供参考。
局限性
- 物质使用障碍在人群样本中患病率相对较低,电子健康记录缺乏详细信息,限制大型数据集在此类分析中的信息量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Substance use disorders (SUDs) are associated with a variety of co-occurring psychiatric disorders and other SUDs, which partly reflects genetic pleiotropy. Polygenic risk scores (PRSs) and phenome-wide association studies are useful in evaluating pleiotropic effects. However, the comparatively low prevalence of SUDs in population samples and the lack of detailed information available in electronic health records limit these data sets' informativeness for such analyses. METHODS: We used the deeply phenotyped Yale-Penn sample (n = 10,610 with genetic data; 46.3% African ancestry, 53.7% European ancestry) to examine pleiotropy for 4 major substance-related traits: alcohol use disorder, opioid use disorder, smoking initiation, and lifetime cannabis use. The sample includes both affected and control subjects interviewed using the Semi-Structured Assessment for Drug Dependence and Alcoholism, a comprehensive psychiatric interview. RESULTS: In African ancestry individuals, PRS for alcohol use disorder, and in European individuals, PRS for alcohol use disorder, opioid use disorder, and smoking initiation were associated with their respective primary DSM diagnoses. These PRSs were also associated with additional phenotypes involving the same substance. Phenome-wide association study analyses of PRS in European individuals identified associations across multiple phenotypic domains, including phenotypes not commonly assessed in phenome-wide association study analyses, such as family environment and early childhood experiences. CONCLUSIONS: Smaller, deeply phenotyped samples can complement large biobank genetic studies with limited phenotyping by providing greater phenotypic granularity. These efforts allow associations to be identified between specific features of disorders and genetic liability for SUDs, which help to inform our understanding of the pleiotropic pathways underlying them.
引用
- Kember RL, Hartwell EE, Xu H, et al. Phenome-wide Association Analysis of Substance Use Disorders in a Deeply Phenotyped Sample. Biol Psychiatry. 2022. PMID: 36273948. doi:10.1016/j.biopsych.2022.08.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。